Global Cord Blood Banking Services Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

  • ID: 4368959
  • Report
  • Region: Global
  • 137 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Americord
  • CBR Systems Inc.
  • Cord Blood America Inc.
  • Cordlife Group Limited
  • CordVida
  • CryoHoldco
  • MORE
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in the cord blood bank market. Cord blood market is expected to grow at 33.5% CAGR from 2012-2020. Public cord blood banks share more revenue as compared to private cord blood banks. Increase in awareness for cord blood storage by the government and private organizations is supporting the growth of UCB stem cell storage market. There are more than 200 public cord blood banks present in world funded by government and non-profit organizations.

Most of the cord blood banks are facing ethical problems regarding sample security. This factor is majorly responsible for decrease in the growth of cord blood banking. This report provides information about current trends for cord blood storage. Current pricing scenario for private cord blood banks and ethical issues faced by public cord blood banks is explained in this report.

Key players in cord blood banking industry includes; NeoStem, Inc., ViaCord, Inc., China Cord Blood Corporation, Cord Blood Registry Systems, Inc., Cord Blood America, Inc.

KEY BENEFITS

Market estimation made in this report are the result of analysis of primary and secondary data collected from authenticated sources
The report analyzes the key strategies adopted by top market players in cord blood banking industry
Impact analysis of top 10 factors to provide market situation to top management of UCB cord blood banks
Value chain analysis, Porter’s five forces, top investment pockets are analyzed and presented in detail in the report
Competitive landscape of key market players is analyzed to provide market intelligence of current trends
SWOT analysis and strategic developments are included in the report for Key players: NeoStem, Inc., ViaCord, Inc., China Cord Blood Corporation, Cord Blood Registry Systems, Inc., Cord Blood America, Inc

KEY MARKET SEGMENTS

BY STORAGE SERVICES

Public cord blood banks
Private cord blood banks

BY GEOGRAPHY

North America
Europe
Asia-Pacific
ROW

KEY AUDIENCES

Pharmaceutical manufacturing companies
Medical device manufacturing companies
Private and government research institutes
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Americord
  • CBR Systems Inc.
  • Cord Blood America Inc.
  • Cordlife Group Limited
  • CordVida
  • CryoHoldco
  • MORE
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY BENEFITS

3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.2.3. Top winning strategies

3.3. TOP PLAYER POSITIONING
3.4. PORTERS FIVE FORCE ANALYSIS
3.5. CORD BLOOD TRANSPLANT FOR TREATMENT OF MEDICAL CONDITIONS

3.5.1. Current scenario

3.5.1.1. Lymphomas
3.5.1.2. Leukemias
3.5.1.3. Transplants for inherited metabolic conditions
3.5.1.4. Transplants for inherited immunological disorders
3.5.1.5. Blood cell proliferation disorders

3.5.2. Future use (Clinical trials)

3.5.2.1. Neurologic Diseases
3.5.2.2. Auto-Immune Diseases
3.5.2.3. Orthopedic Diseases
3.5.2.4. Cardiovascular Diseases
3.5.2.5. Becker Muscular Dystrophy
3.5.2.6. Stem cells & gene therapy for inherited disorders
3.5.2.7. Stem Cells & Gene Therapy for Inherited Disorders
3.5.2.8. Stem Cell Transplantation for New Indications

3.6. REGULATORY SCENARIOS

3.6.1. FDA Biologics License Application (FDA BLA)
3.6.2. American Association of Blood Banks (AABB)
3.6.3. Clinical Laboratory Improvement Amendments (CLIA)
3.6.4. American Association of Tissue Banks (AATB)
3.6.5. Joint Accreditation Committee - ISCT - EBMT (JACIE)
3.6.6. Human Tissue Authority (HTA) - UK
3.6.7. Foundation for the Accreditation of Cellular Therapy (FACT)
3.6.8. International Organization for Standardization (ISO)
3.6.9. NetCord

3.7. MARKET DYNAMICS

3.7.1. Drivers

3.7.1.1. Increase in R&D activities for application of cord blood
3.7.1.2. Rise in funds for public storage
3.7.1.3. Increase in prevalence of fatal chronic diseases

3.7.2. Restraints

3.7.2.1. Legal and ethical issues during collection
3.7.2.2. Difficulty of finding a match in the donor list
3.7.2.3. High processing and storage cost for cord blood
3.7.2.4. Lack of awareness

3.7.3. Opportunities

3.7.3.1. Advancement in therapeutic application
3.7.3.2. Untapped opportunities in developing regions
3.7.3.3. Initiatives to spread awareness

CHAPTER 4 CORD BLOOD BANKING SERVICES MARKET, BY STORAGE SERVICES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PUBLIC CORD BLOOD BANKS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. PRIVATE CORD BLOOD BANKS

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 CORD BLOOD BANKING SERVICES MARKET, BY GEOGRAPHY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. France market size and forecast
5.3.3.2. Germany market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Rest of Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. India market size and forecast
5.4.3.4. Singapore market size and forecast
5.4.3.5. Malaysia market size and forecast
5.4.3.6. Thailand market size and forecast
5.4.3.7. Indonesia market size and forecast
5.4.3.8. Philippines market size and forecast
5.4.3.9. Hong Kong (including Macau) market size and forecast
5.4.3.10. South Korea market size and forecast
5.4.3.11. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Latin America market size and forecast
5.5.3.2. Middle East and Africa market size and forecast
5.5.3.3. Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. AMAG PHARMACEUTICALS, INC.

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments

6.2. AMERICORD REGISTRY LLC

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Key strategic moves and developments

6.3. CHINA CORD BLOOD CORPORATION

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Business performance
6.3.5. Key strategic moves and developments

6.4. CORD BLOOD AMERICA, INC.

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Business performance
6.4.5. Key strategic moves and developments

6.5. CORDLIFE GROUP LIMITED

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.5.6. Key strategic moves and developments

6.6. CORDVIDA

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments

6.7. CRYO-CELL INTERNATIONAL, INC.

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance

6.8. CRYOHOLDCO DE LATINOAMERICA, S.A.P.I. DE C.V.

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments

6.9. ESPERITE N.V.

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance

6.10. LIFEFORCE CRYOBANK SCIENCES, INC

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Product portfolio

6.11. NATIONAL CORD BLOOD PROGRAM

6.11.1. Company overview
6.11.2. Company snapshot
6.11.3. Operating business segments

6.12. PERKINELMER, INC.

6.12.1. Company overview
6.12.2. Company snapshot
6.12.3. Operating business segments
6.12.4. Product portfolio
6.12.5. Business performance

6.13. VIRGIN GROUP LIMITED

6.13.1. Company overview
6.13.2. Company snapshot
6.13.3. Operating business segments
6.13.4. Product portfolio

6.14. VITA 34 AG

6.14.1. Company overview
6.14.2. Company snapshot
6.14.3. Operating business segments
6.14.4. Product portfolio
6.14.5. Business performance
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Americord
  • CBR Systems Inc.
  • Cord Blood America Inc.
  • Cordlife Group Limited
  • CordVida
  • CryoHoldco
  • MORE
According to a new report titled, Cord Blood Banking Services Market by Storage Services: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global cord blood banking services market accounted for $1,126 million in 2016, and is estimated to reach at $2,772 million by 2023, registering a CAGR of 13.8% from 2017 to 2023. North America was the highest revenue contributor in the global market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Umbilical cord blood is collected from the nursing homes and hospitals post the delivery of a baby. This blood contains a large amount of stem cells, which can be used to treat various diseases. The public cord blood banks are operated by the non-profit organizations with the help of government funding, which are donated by families after the delivery of baby. This donated cord blood is available for multiple applications such as for research purposes and treatment of genetic diseases.

The private cord blood banks are privately owned banks where the parents can store the cord blood of newborn for future use such as for treatment of certain chronic disease. In private banks, charges are incurred for the collection, processing, and storage of cord blood. Thus, the public cord blood banks possess competitive advantages in developed regions such as North America and Europe.

The cord blood banking services market is expected to witness a moderate growth during the forecast period. The key drivers for the market growth are adoption of novel marketing strategies by key players, increase in R&D activities for application of cord blood, and rise in funding for establishment of public cord blood storage banks. However, high cost associated with the processing, difficulty in finding a match in the donor list of public cord blood banks, and legal & ethical issues related to collection of cord blood are expected to hamper this growth. Conversely, advancement in the stem cell therapeutics and presence of untapped potential in the developing and developed regions are expected to provide various opportunities to the cord blood banking services.

The private cord blood banks segment occupied a dominant part of the market in 2016, and is expected to grow at the highest rate. This is attributable to the better service provided by the private banks to their customers, guarantee of storing the cord blood for a specified period, and immediate retrieval of the cord blood when required for treatment of any genetic disease.

In 2016, North America accounted for maximum contribution to the total revenue generated, owing to the market maturity, high awareness among the expectant parents, presence of high disposable income, and high adoption rate of cord blood storage services. However, Asia-Pacific is expected to witness the highest growth during the analysis period, attributable to rise in awareness related to the benefits of storing cord blood, increase in focus of key players to expand their services, and rise in disposable income.

Key Findings of the Cord Blood Banking Services Market:

The private cord blood bank segment is anticipated to grow at the highest rate during the analysis period.
Germany was the highest revenue-generating country in the European market in 2016, and is expected to continue its dominance during the forecast period.
In 2016, North America dominated global cord blood banking services market, and is estimated to continue this trend in the near future.
China is expected to grow at the highest rate in the Asia-Pacific region.
Latin America was the largest contributor in the LAMEA region.
The key companies profiled in the report include China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Limited, Cryo-Cell International, Inc., Cryo-Save AG, Lifeforce Cryobanks, National Cord Blood Program, ViaCord, Inc., Virgin Health Bank, CordVida, Americord, CryoHoldco, and Vita34.
Note: Product cover images may vary from those shown
5 of 5
  • China Cord Blood Corporation
  • Cord Blood America Inc.
  • CBR Systems Inc.
  • Cordlife Group Limited
  • Cryo-Cell International Inc.
  • Cryo-Save AG
  • Lifeforce Cryobanks
  • National Cord Blood Program
  • ViaCord Inc.
  • Virgin Health Bank
  • CordVida
  • Americord
  • CryoHoldco
  • Vita34
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll